Article Information
History
- December 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Simone Weber1,*,
- Victoria Kehl2,*,
- Johanna Erber3,8,
- Karolin I. Wagner1,
- Ana-Marija Jetzlsperger4,
- Theresa Burrell1,
- Kilian Schober5,
- Philipp Schommers6,7,
- Max Augustin6,7,
- Claudia S. Crowell1,8,
- Markus Gerhard1,8,
- Christof Winter9,
- Christoph D. Spinner3,8,
- Ulrike Protzer4,
- Dieter Hoffmann4,
- Elvira D’Ippolito1,§ and
- Dirk H Busch1,8,§,#
- 1Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
- 2Institute for AI and Informatics in Medicine, School of Medicine, Technical University of Munich, Munich, Germany
- 3Department of Internal Medicine II, University Hospital Rechts Der Isar, School of Medicine, Technical University of Munich, Munich, Germany
- 4Institute of Virology, School of Medicine, Technical University of Munich, Munich, Germany
- 5Mikrobiologisches Institut – Klinische Mikrobiologie, Immunologie und Hygiene, Universitäts-klinikum Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, 91054 Erlangen, Germany
- 6Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
- 7German Center for Infection Research (DZIF), partner site Bonn-Cologne, Germany
- 8German Center for Infection Research (DZIF), partner site Munich, Germany
- 9Institute of Clinical Chemistry and Pathobiochemistry, School of Medicine, Technical University of Munich, Germany
- ↵#CORRESPONDING AUTHOR
Prof. Dr. med. Dirk H. Busch, Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Trogerstr. 30, 81675 Munich, Germany, Tel. +49-89-4140-4120, Fax +49-89-4140-4868, Email: dirk.busch{at}tum.de
Posted December 24, 2021.
CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients
